![](/img/cover-not-exists.png)
Fixed doses of N8-GP prophylaxis maintain moderate-to-mild factor VIII levels in the majority of patients with severe hemophilia A
Chowdary, Pratima, Carcao, Manuel, Holme, Pål A., Jiménez-Yuste, Victor, Lentz, Steven R., Møss, Judi, Poulsen, Lone H., Shen, Chunduo, Tosetto, Alberto, Wheeler, Allison, Santagostino, ElenaVolume:
3
Language:
english
Journal:
Research and Practice in Thrombosis and Haemostasis
DOI:
10.1002/rth2.12220
Date:
July, 2019
File:
PDF, 588 KB
english, 2019